Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Columbia University
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
University of Nebraska
Bellicum Pharmaceuticals
Burnasyan Federal Medical Biophysical Center
University of Erlangen-Nürnberg Medical School
Baylor College of Medicine